- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02144597
Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass (LCD)
February 24, 2021 updated by: Imperial College London
The Effect of a 2-week vs. 6-week Low-calorie Diet (LCD) Followed by Roux-en-Y Gastric Bypass (RYGB) on Body Composition and Surgery Outcomes in Obese Humans: a Dietary Intervention and Magnetic Resonance Imaging Study
Losing weight before undergoing Roux-en-Y gastric bypass (RYGB) surgery may reduce liver fat content and size thereby improving surgical outcomes.
This study aims to investigate whether a 2-week or 6-week pre-operative liquid formula low-calorie diet (LCD) reduces liver fat further than a conventional food diet prior to RYGB using magnetic resonance imaging (MRI).
The hypothesis is that the 2-week and 6-week liquid formula LCD will reduce liver fat further than the conventional food pre-operative diet.
Study Overview
Status
Completed
Conditions
Detailed Description
The morbidly obese subjects (BMI higher then 40 kg/m2) were randomised and assessed at baseline (week 0).
After 2 weeks on a low-calorie diet (LCD), participants underwent either Roux-en-Y gastric bypass (RYGB) or continued with a LCD for 4 weeks.The participants will reassess at week 6.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Greater London
-
London, Greater London, United Kingdom, W12 0NN
- Imperial Clinical Research Facility
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients undergoing Roux-en-Y gastric bypass at Imperial Weight Centre
- aged 18 to 60 years
- boby mass index of 35 to 55 kg/m2
Exclusion Criteria:
- Claustrophobia
- Pacemaker, metal implant, clips, implanted device, shrapnel or bullets, metal in eyes that precludes magnetic resonance imaging
- Current pregnancy or breast feeding for females (as determined by a pregnancy test)
- A full term pregnancy within the last year for females
- Treatment with any medication that might affect the study outcomes
- Haemorrhagic disorders and anticoagulant treatment
- History of cancer, excluding skin cancer
- History of severe or multiple allergies, severe adverse drug reaction or leucopenia
- Smokers
- Regular drinkers of more than three units of alcohol daily
- History of, or current evidence of, abuse of alcohol or any drug substance, licit or illicit
- Regular intake of over-the-counter (OTC) medication (other than the occasional paracetamol/aspirin)
- Poor compliers or subjects unlikely to commit to the 26 week study duration
- Blood donation within the 12 week period before the initial study dose
- Use of monoamine oxidase inhibitors (MAOIs) as anti depressant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 2-week LCD and Roux-en-Y gastric bypass (RYGB)
A 2-week liquid formula low-calorie diet (LCD) will be administered for 2 weeks prior to Roux-en-Y gastric bypass.
The diet will provide 800kcal per day in the form of powdered milkshakes and soups
|
The liquid formula low-calorie diet (LCD) will provide 800kcal/day from powdered milkshakes and soups.
The diet will be provided by Cambridge Weight Plan.
Other Names:
Participant went through Roux-en-Y gastric bypass (RYGB) surgery
|
|
Active Comparator: 6-week LCD
A 6-week liquid formula low-calorie diet (LCD) will be administered for 6 weeks prior to Roux-en-Y gastric bypass.
The diet will provide 800kcal per day in the form of powdered milkshakes and soups
|
The liquid formula low-calorie diet (LCD) will provide 800kcal/day from powdered milkshakes and soups.
The diet will be provided by Cambridge Weight Plan.
Other Names:
|
|
Other: Control diet
1000 calorie diet
|
Participant went through Roux-en-Y gastric bypass (RYGB) surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Intra-hepatocellular Lipid Content (IHCL) Following the Pre-operative Diet
Time Frame: at 2 weeks or 6 weeks depending on group
|
Intra-hepatocellular lipid content will be measured by magnetic resonance spectroscopy
|
at 2 weeks or 6 weeks depending on group
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Intra-hepatocellular Lipid Content (IHCL) Following Roux-en-Y Gastric Bypass
Time Frame: at 1-month following Roux-en-Y gastric bypass
|
Intra-hepatocellular lipid content (IHCL) will be compared between groups at 1 month following Roux-en-Y gastric bypass
|
at 1-month following Roux-en-Y gastric bypass
|
|
Change in Intra-hepatocellular Lipid Content (IHCL) Following Roux-en-Y Gastric Bypass
Time Frame: at 6 months following Roux-en-Y gastric bypass
|
Intra-hepatocellular lipid content (IHCL) will be compared between groups at 6 months following Roux-en-Y gastric bypass
|
at 6 months following Roux-en-Y gastric bypass
|
|
Complexity of Surgery
Time Frame: at the time of surgery
|
Complexity of surgery will be assessed by the surgeon at the time of surgery (either after 2 weeks for the Control group and 2-week LCD group or after 6 weeks for the 6-week LCD group) The complexity of the surgery was assessed through a score on a complexity scale based on questionnaires previously published by Anders Thorell"s and David Edholm"s groups (Edholm et al., 2011, Van Nieuwenhove et al., 2011).
The scores (1-5) for 7 variables: exposure, bleeding, difficulty in dissection, difficulty in reconstruction, surgical judgment, technical demand and psychological stress were combined into a complexity of surgery score with a minimum of 7 (very little complexity) and a maximum of 35 (very high complexity).
|
at the time of surgery
|
|
Operative Time
Time Frame: at the time of surgery
|
The operative time will be recorded at the time of surgery by the operating surgeon (either after 2 weeks for the Control group and 2-week LCD group or after 6 weeks for the 6-week LCD group)
|
at the time of surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Prof Gary S Frost, RD PhD, Imperial College London
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Bottin JH, Balogun B, Thomas EL, Fitzpatrick JA, Moorthy K, Leeds AR, Bell JD, Frost GS. Changes in body composition induced by pre-operative liquid low-calorie diet in morbid obese patients undergoing Roux-en-Y gastric bypass. Obesity reviews (March 2014), 15 (suppl 2): 129-176. (T5:S24.05). doi: 10.1111/obr.12151
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2011
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
May 9, 2014
First Submitted That Met QC Criteria
May 19, 2014
First Posted (Estimate)
May 22, 2014
Study Record Updates
Last Update Posted (Actual)
March 18, 2021
Last Update Submitted That Met QC Criteria
February 24, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRO1668
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Fat
-
University of Eastern FinlandKuopio University HospitalCompleted
-
University of OxfordCompletedNAFLD | Fat; LiverUnited Kingdom
-
Wageningen UniversityCompletedNonalcoholic Fatty Liver Disease | Hepatic Fat AccumulationNetherlands
-
University of Wisconsin, MadisonNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingHealthy | Iron Overload | Liver FatUnited States
-
Istanbul Gelisim UniversityMarmara UniversityCompletedObesity | Liver Fat | Fatty Liver DiseaseTurkey
-
King's College Hospital NHS TrustSamsung MedisonRecruitingHepatitis | Liver Fat | NAFLD | Fibrosis, Liver | Liver Disease Chronic | Liver Steatoses | NASH With FibrosisUnited Kingdom
-
Yonsei UniversityCompleted
-
Massachusetts General HospitalRecruitingFatty Liver | Liver Fat | Non-Alcoholic Fatty Liver Disease | Intermittent Fasting | Fatty Liver, NonalcoholicUnited States
-
Protein Supplies SLCompleted
-
University of California, San DiegoCompletedLiver Diseases | Liver Fat | Hepatic Steatosis | Non-Alcoholic Fatty Liver Disease | Nutritional and Metabolic DiseaseUnited States
Clinical Trials on Control diet
-
Fazer GroupNokia Technologies Oy; Nightingale Health Oy; Tekes - the Finnish Funding Agency... and other collaboratorsCompletedCognitive Performance | Physiological Stress | LDL CholesterolFinland
-
Lund UniversityLund University HospitalCompletedObesity | Diet Modification | Cardiovascular Risk FactorSweden
-
Universidade Federal do Rio de JaneiroCompletedType 1 Diabetes MellitusBrazil
-
Isfahan University of Medical SciencesCompleted
-
Marjukka KolehmainenLund University; Uppsala University; Aarhus University Hospital; University of... and other collaboratorsCompletedCardiovascular Diseases | Insulin Resistance | Type 2 Diabetes | Impaired Glucose Tolerance | Abdominal ObesitySweden, Denmark, Finland, Iceland, Norway
-
University of Missouri-ColumbiaNational Institutes of Health (NIH)Not yet recruitingPostoperative Cognitive DysfunctionUnited States
-
Fundació Institut de Recerca de l'Hospital de la...University of BarcelonaCompleted
-
University of GeorgiaCompletedInflammation | ObesityUnited States
-
Medical University of WarsawCompletedDietary Intervention | Metabolic Cardiovascular Syndrome | Vegetarian Diet | Mediterranean Diet | Vegan Diet | Obesity and OverweightPoland
-
Purdue UniversityAlliance for Potato Research and EducationUnknownHypertensive DiseaseUnited States